Exelixis (EXEL) Misses Q1 EPS by 6c, Misses on Revenue

Go back to Exelixis (EXEL) Misses Q1 EPS by 6c, Misses on Revenue

Exelixis (EXEL) PT Lowered to $27 at RBC Capital

May 1, 2024 6:30 AM EDT

RBC Capital analyst Kennen MacKay lowered the price target on Exelixis (NASDAQ: EXEL) to $27.00 (from $28.00) while maintaining a Outperform rating.

The analyst comments "Cabometyx sales were notably lighter than typical though 1Q softness is a trend (also in '22 & '23) and we... More